Tumor type | Target site(s) | Reference(s) | Role of target site |
---|---|---|---|
Breast cancer | FAK, PAK1, EGFR, KLF4, HoxB3, SET8 | Suppressor | |
Lung cancer | PA28γ, BCL-2, EGFR, SLC7A5, HuR | Suppressor | |
Hepatocellular carcinoma | CCNE1, PI3KCD, mTOR, p70S6Â K, GSK-3B | Suppressor | |
Glioma | EGFR, C-KIT, FAK, ERK, ciRS-7 | Suppressor | |
Colorectal cancer | XRCC2, PAX6, YY1 | Suppressor | |
Gastric cancer | EGFR, IGF1R | Suppressor | |
Acute myelocytic leukemia | TET2 | [58] | Suppressor |
Urothelium carcinoma | FGFR3 | [59] | Suppressor |
Cervical cancer | XIAP | [60] | Suppressor |
Renal carcinoma | None reported | [61] | Oncogene |
Melanoma | IRS-2 | [62] | Suppressor |
Ovarian cancer | EGFR, ERK | [50] | Suppressor |
Oral cancer | RECK | [63] | Oncogene |
Neuroblastoma | 4-HPR, EGCG | [64] | Suppressor |
Pancreatic carcinoma | MAPK | [65] | suppressor |
Pleural mesothelioma | None reported | [66] | Suppressor |
Schwannoma tumors | EGFR, ACK1, PAK1 | [67] | Suppressor |
Tongue squamous carcinoma | IGF1R | [68] | Suppressor |